<DOC>
	<DOC>NCT01779856</DOC>
	<brief_summary>The primary objective of this study is to estimate the proportion of hemodialysis patients experiencing clinically significant cardiac arrhythmias over a 6-month period using continuous cardiac monitoring with an implanted Medtronic Reveal Insertable Cardiac Monitor (ICM) device.</brief_summary>
	<brief_title>Study the Characteristics of Cardiac Related Events in Hemodialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>21 years of age or older and is willing to be implanted with the Reveal ICM Currently on hemodialysis at least three times per week OR has an estimated glomerular filtration rate (eGFR) of &lt; 15 mL/min/1.73m^2 and is expected to begin hemodialysis within 2 months. Subject is willing and able to comply with the protocol Currently enrolled in an interventional study that may interfere with the Monitoring in Dialysis protocol Not suitable for Reveal ICM implantation Has an existing hemodialysis catheter that may interfere with the Reveal ICM implantation site Has a recent infection Is currently on hemodialysis with a hemoglobin &lt; 10 g/dL Has endstage liver failure or has had thoracic surgery within the past 6 months Has an existing pacemaker, implantable cardioverterdefibrillator (ICD) or cardiac resynchronization device Is scheduled for renal transplantation or will likely be transplanted within 6 months Is currently on home hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>End Stage Renal Disease, Hemodialysis, Arrhythmia, Reveal ICM</keyword>
</DOC>